Skip to main content
Fig. 2 | Trials

Fig. 2

From: Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial

Fig. 2

SPIRIT figure showing time points for enrolment, interventions and assessment. *Laboratory examination includes complete blood count, rheumatoid factor, Anticyclic citrullinated peptide antibody, C-reactive protein, erythrocyte sedimentation rate, liver function tests (aspartate aminotransferase, alanine aminotransferase) and renal function (creatinine, urea). ACR20/50/70 improvement in American College of Rheumatology criteria of 20%/50%/70%, CDAI Clinical Disease Activity Index, DAS28 Disease Activity Score in 28 joints, MTX methotrexate, SDAI Simplified Disease Activity Index

Back to article page